Kuehne+Nagel establishes network of cross dock warehouses in support of healthcare market in U.S.

• New network of eight, temperature-controlled, GxP-compliant facilities for cross-docking operations
• Ideal for healthcare products such as temperature-sensitive medicines and vaccines, medical devices and diagnostic kits
• Cross-docking solution optimizes supply chain efficiencies and reduces CO2 emissions

NEW JERSEY CITY : With this solution, Kuehne+Nagel addresses the growing need of the healthcare market for more sustainable and cost-optimized supply chains, in an industry where precise temperature control and timely delivery are paramount.

The cross-dock concept features the loading and unloading of sea freight temperature-controlled containers in a GxP-compliant warehouse near an ocean port, allowing for the prompt return of empty containers to the port. At the temperature-controlled warehouse, the containers are sorted and optimized for road transportation to their final destination. This reduces the use of multiple containers and eliminates or lowers detentions charges due to a fast turnaround of container management.  

Kuehne+Nagel’s expanded network of cross-dock facilities now includes warehouses in Philadelphia, Pennsylvania; Atlanta, Georgia; Wilmington, North Carolina; and Los Angeles, California. Four additional locations across the country will open in 2024. All of the facilities offer multiple temperature ranges and comply with Kuehne+Nagel’s HealthChain certification, ensuring the highest global quality standards for transporting, handling, and storing of healthcare products.

“Cross-docking optimizes the time that products spend in transit, streamlines the handling process, and reduces costs and CO2 emissions,” said Jeff Garcia, Industry Champion Healthcare for Kuehne+Nagel. “We began this concept as a pilot program with a large, global human and animal health customer for their animal health division at one warehouse, resulting in a double-digit savings of costs in the container inbound process and cutting CO2 emissions by nearly half. Based on this success, we are proud to be expanding this offering to the healthcare market across the United States.”

About Kuehne+Nagel

With approximately 81,000 employees at almost 1,300 sites in close to 100 countries, the Kuehne+Nagel Group is one of the world’s leading logistics providers. Headquartered in Switzerland, Kuehne+Nagel is listed in the Swiss blue-chip stock market index, the SMI. The Group is the global number one in air and sea logistics and has strong market positions in road and contract logistics. 

Kuehne+Nagel is the logistics partner of choice for 400,000 customers worldwide. Using its global network, logistics expertise and data-based insights, the Group provides end-to-end supply chain solutions for global companies and industries. As a member of the Science Based Target Initiative (SBTi), Kuehne+Nagel is committed to sustainable logistics by reducing its own environmental footprint and by supporting its customers with low-carbon logistics solutions.